Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Expert Opinion on Biological Therapy|June 27, 2020
Antibody-drug conjugates for the treatment of urothelial carcinomaPraful Ravi, Bradley A McGregorExpert Opinion on Investigational Drugs|September 19, 2019
Enfortumab Vedotin, a fully human monoclonal antibody against Nectin 4 conjugated to monomethyl auristatin E for metastatic urothelial CarcinomaBradley A McGregor, Guru SonpavdeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2021
New Insights into the Molecular Profile of Penile Squamous Cell CarcinomaBradley A McGregor, Guru P SonpavdeEuropean Urology Focus|March 27, 2019
Rare Genitourinary Malignancies: Current Status and Future Directions of ImmunotherapyBradley A McGregor, Guru P SonpavdeCancers|December 23, 2022
The Continuing Question of Adjuvant Therapy in Clear Cell Renal Cell CarcinomaStephanie A Berg, Bradley A McGregorCurrent Treatment Options in Oncology|February 5, 2024
One Size Fits Some: Approaching Rare Malignancies of the Urinary TractStephanie A Berg, Bradley A McGregorThe Urologic Clinics of North America|July 1, 2020
Management of Metastatic Renal Cell Carcinoma with Variant HistologiesRonan Flippot, Vijay Damarla, Bradley A McGregorEuropean Urology Focus|November 30, 2017
Immunotherapy in the ElderlyAly-Khan A Lalani, Dominick Bossé, Bradley A McGregor, et al.American Journal of Hematology|March 5, 2009
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemiaBradley A McGregor, Alexander W Brown, Michael B Osswald, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Reassessing the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in 2019Sarah P Psutka, Steven L Chang, David Cahn, et al.Pageof 7